NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »           NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »          NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »
Research / Case Study / Case Study: Genetic Test Payment Integrity

Case Study: Genetic Test Payment Integrity

Payment Integrity Edits Identify $26.5M in Inappropriate Genetic Testing Payments

Driven by the rapid and ongoing increase in the number of genetic tests available on the market, genetic testing spending is projected to increase from $13B in 2020 to $29B by 2026. The growth and complexity of these tests create clinical and payment appropriateness challenges. And, overpayments still occur even if a plan has an effective utilization management program in place.

In this case study, we describe the payment integrity program that InformedDNA implemented with a large national health plan with more than nine million covered lives. By improving test identification, reviewing claims against medical policy, and identifying payment variations, the program enabled $26.5M in payment reductions on edited genetic testing claims a reduction equal to $0.25M.

With the nation’s largest employee staff of lab-independent genetics specialists, InformedDNA enables health plans to stay ahead of the curve by augmenting a plan’s in-house team with comprehensive clinical genetics expertise. We empower health plans to promote precision medicine, optimize spending, and avoid unnecessary and unpleasant experiences for members and providers.

Fill out the form below to download your FREE copy of our Case Study on Genetic Test Payment Integrity

Fill out the form below to download your FREE copy of our Case Study

Recent Posts

The Cancer Letter: Joint byline, ‘Is gastrectomy indicated?’

A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates. InformedDNA, FORCE: Facing Our Risk of Cancer Empowered, and No Stomach For Cancer, collaborate as patient advocates, educators, and experts to support individuals and families impacted by gastric cancer to help them navigate this complex genetic landscape. Subscribers to The Cancer Letter can login to read the full article.

Read More »

How can we help?

Reach out today to speak with a specialist and learn more about how our decades of experience and breadth of knowledge across all genetics subspecialties can work for your organization.
×